Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study
Background: Familial Hypercholesterolemia (FH) is an underdiagnosed condition with an increased cardiovascular risk. It is unknown whether lipid accumulation plays a role in structural myocardial changes. Cardiovascular Magnetic Resonance (CMR) is the reference technique for the morpho-functional ev...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f00835c77da9482894abb416cebc919c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f00835c77da9482894abb416cebc919c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f00835c77da9482894abb416cebc919c2021-12-04T04:34:44ZMyocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study2352-396410.1016/j.ebiom.2021.103735https://doaj.org/article/f00835c77da9482894abb416cebc919c2021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352396421005296https://doaj.org/toc/2352-3964Background: Familial Hypercholesterolemia (FH) is an underdiagnosed condition with an increased cardiovascular risk. It is unknown whether lipid accumulation plays a role in structural myocardial changes. Cardiovascular Magnetic Resonance (CMR) is the reference technique for the morpho-functional evaluation of heart chambers through cine sequences and for myocardial tissue characterization through late gadolinium enhancement (LGE) and T1 mapping images. We aimed to assess the prevalence of myocardial fibrosis in FH patients. Methods: Seventy-two asymptomatic subjects with genetically confirmed FH (mean age 49·24, range 40 to 60 years) were prospectively recruited along with 31 controls without dyslipidaemia matched for age, sex, BMI, and other cardiovascular risk factors. All underwent CMR including cine, LGE, pre- and post-contrast T1 mapping. Extracellular volume (ECV) and enhancement rate of the myocardium (ERM = difference between pre- and post-contrast myocardial T1, normalized by pre-contrast myocardial T1) were calculated. Findings: Five FH patients and none of the controls had intramyocardial LGE (p= 0·188). While no changes in Native T1 and ECV were found, post-contrast T1 was significantly lower (430·6 ± 55ms vs. 476·1 ± 43ms, p<0·001) and ERM was higher (57·44± 5·99 % vs 53·04±4·88, p=0·005) in HeFH patients compared to controls. Moreover, low post-contrast T1 was independently associated with the presence of xanthoma (HR 5·221 [1·04-26·28], p= 0·045). A composite score combining the presence of LGE, high native T1 and high ERM (defined as ≥ mean ± 1·5 SD) was found in 20·8% of the HeFH patients vs. 0% in controls (p<0·000, after adjustment for main confounders). Interpretation: CMR revealed early changes in myocardial tissue characteristics in HeFH patients, that should foster further work to better understand and prevent the underlying pathophysiological processes.Antonio GalloPhilippe GiralDavid RosenbaumAlessandro MattinaAli KilincAlain GironKhaoula BouaziziMoussa Gueda MoussaJoe-Elie SalemAlain CarriéValérie CarreauSophie BéliardRanda BittarPhilippe CluzelEric BruckertAlban RedheuilNadjia KachenouraElsevierarticleFamilial hypercholesterolemiacardiovascular imagingcardiac magnetic resonanceprimary preventiongenetic dyslipidaemiacardiovascular riskMedicineRMedicine (General)R5-920ENEBioMedicine, Vol 74, Iss , Pp 103735- (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Familial hypercholesterolemia cardiovascular imaging cardiac magnetic resonance primary prevention genetic dyslipidaemia cardiovascular risk Medicine R Medicine (General) R5-920 |
spellingShingle |
Familial hypercholesterolemia cardiovascular imaging cardiac magnetic resonance primary prevention genetic dyslipidaemia cardiovascular risk Medicine R Medicine (General) R5-920 Antonio Gallo Philippe Giral David Rosenbaum Alessandro Mattina Ali Kilinc Alain Giron Khaoula Bouazizi Moussa Gueda Moussa Joe-Elie Salem Alain Carrié Valérie Carreau Sophie Béliard Randa Bittar Philippe Cluzel Eric Bruckert Alban Redheuil Nadjia Kachenoura Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study |
description |
Background: Familial Hypercholesterolemia (FH) is an underdiagnosed condition with an increased cardiovascular risk. It is unknown whether lipid accumulation plays a role in structural myocardial changes. Cardiovascular Magnetic Resonance (CMR) is the reference technique for the morpho-functional evaluation of heart chambers through cine sequences and for myocardial tissue characterization through late gadolinium enhancement (LGE) and T1 mapping images. We aimed to assess the prevalence of myocardial fibrosis in FH patients. Methods: Seventy-two asymptomatic subjects with genetically confirmed FH (mean age 49·24, range 40 to 60 years) were prospectively recruited along with 31 controls without dyslipidaemia matched for age, sex, BMI, and other cardiovascular risk factors. All underwent CMR including cine, LGE, pre- and post-contrast T1 mapping. Extracellular volume (ECV) and enhancement rate of the myocardium (ERM = difference between pre- and post-contrast myocardial T1, normalized by pre-contrast myocardial T1) were calculated. Findings: Five FH patients and none of the controls had intramyocardial LGE (p= 0·188). While no changes in Native T1 and ECV were found, post-contrast T1 was significantly lower (430·6 ± 55ms vs. 476·1 ± 43ms, p<0·001) and ERM was higher (57·44± 5·99 % vs 53·04±4·88, p=0·005) in HeFH patients compared to controls. Moreover, low post-contrast T1 was independently associated with the presence of xanthoma (HR 5·221 [1·04-26·28], p= 0·045). A composite score combining the presence of LGE, high native T1 and high ERM (defined as ≥ mean ± 1·5 SD) was found in 20·8% of the HeFH patients vs. 0% in controls (p<0·000, after adjustment for main confounders). Interpretation: CMR revealed early changes in myocardial tissue characteristics in HeFH patients, that should foster further work to better understand and prevent the underlying pathophysiological processes. |
format |
article |
author |
Antonio Gallo Philippe Giral David Rosenbaum Alessandro Mattina Ali Kilinc Alain Giron Khaoula Bouazizi Moussa Gueda Moussa Joe-Elie Salem Alain Carrié Valérie Carreau Sophie Béliard Randa Bittar Philippe Cluzel Eric Bruckert Alban Redheuil Nadjia Kachenoura |
author_facet |
Antonio Gallo Philippe Giral David Rosenbaum Alessandro Mattina Ali Kilinc Alain Giron Khaoula Bouazizi Moussa Gueda Moussa Joe-Elie Salem Alain Carrié Valérie Carreau Sophie Béliard Randa Bittar Philippe Cluzel Eric Bruckert Alban Redheuil Nadjia Kachenoura |
author_sort |
Antonio Gallo |
title |
Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study |
title_short |
Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study |
title_full |
Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study |
title_fullStr |
Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study |
title_full_unstemmed |
Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study |
title_sort |
myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/f00835c77da9482894abb416cebc919c |
work_keys_str_mv |
AT antoniogallo myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT philippegiral myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT davidrosenbaum myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT alessandromattina myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT alikilinc myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT alaingiron myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT khaoulabouazizi myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT moussaguedamoussa myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT joeeliesalem myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT alaincarrie myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT valeriecarreau myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT sophiebeliard myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT randabittar myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT philippecluzel myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT ericbruckert myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT albanredheuil myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy AT nadjiakachenoura myocardialfibrosisassessedbymagneticresonanceimaginginasymptomaticheterozygousfamilialhypercholesterolemiathecholcoeurstudy |
_version_ |
1718373005375045632 |